Check out the above video about our COVID19 drug repurposing work or go to: https://youtu.be/0HFHfTd9-Y8
David Fajgenbaum, MD, MBA, MSc, is a groundbreaking physician-scientist, disease hunter, speaker, and bestselling author of the acclaimed memoir, Chasing My Cure: A Doctor’s Race to Turn Hope Into Action. Best known as the ‘doctor who cured himself’ (Doctor Cure Thyself, NY Times), Fajgenbaum went from being a beast-like college Quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, he spearheaded an innovative approach to research and discovered a possible treatment that has put him into an extended remission. Now, he is spreading this approach to other diseases (His method could save millions, CNN) and sharing lessons he learned about living from nearly dying through Chasing My Cure, which has been translated into four languages and named one of the “Best Non-Fiction Books of 2019” by Next Big Ideas Club.
This is very inspirational to me. I too, have Multicentric Castleman’s disease too. I have lived for 18 years with it. Thank you, Dr. Fajenbaum and team, for all you do.
Thanks so much, Trudie! We will keep fighting with everything we’ve got against CD and COVID19!
If you haven’t gotten a chance to get involved in contributing your data and samples to the fight, check out this link for more info on ways you can contribute to the fight: https://cdcn.org/join-the-fight/get-involved/
The video was well done! I am curious as to what you found (if any legitimate) any articles about the anti-malaria drugs. I look forward to the discovery of useful drugs, and a better understanding of how the COVID-19 virus works. I hope the latter can lead to finding some weak links in the virus’ life cycle.
Thanks Walter! Studies of the anti-malarial drugs have had very conflicting results to date. Some have shown a positive effect, some have shown no effect, and others have shown harmful effects (when combined with azithromycin). There seem to be some promising drugs but more research through well-controlled clinical trials are needed.